- Potential drug interactions in travelers with chronic illnesses: a large retrospective cohort studyShmuel Stienlauf
The Center of Geographic Medicine, The Chaim Sheba Medical Center, Tel Hashomer 52621, Israel The Departments of Internal Medicine, The Chaim Sheba Medical Center, Tel Hashomer 52621, Israel The Sackler School of Medicine, Tel Aviv University, Tel Aviv 69978, Israel Electronic address
Travel Med Infect Dis 12:499-504. 2014..Data regarding the prevalence of potential interactions between travel-related medications (TRM) and chronic medications in use, or medical conditions of travelers to developing countries are limited...
- Malignant diseases and mortality in blood donors infected with human T-lymphotropic virus type 1 in IsraelShmuel Stienlauf
Department of Medicine C, Sheba Medical Center, Tel Hashomer, 52621 Israel The Center of Geographic Medicine, Sheba Medical Center, Tel Hashomer, Israel Tel Aviv University, Sackler School of Medicine, Tel Aviv, Israel Electronic address
Int J Infect Dis 17:e1022-4. 2013..The aim of this study was to evaluate the prevalence of malignant disorders and mortality among a cohort of Israelis diagnosed as HTLV-1 carriers during routine blood unit screening...
- Epidemiology of human T-cell lymphotropic virus type 1 infection in blood donors, IsraelShmuel Stienlauf
Sheba Medical Center, Tel Hashomer, Israel
Emerg Infect Dis 15:1116-8. 2009..In donors originating from Eastern Europe, the Middle East, and Latin America, prevalences are 7.7, 14.6, and 20.4, respectively. HTLV-1 prevalence may be high outside areas where HTLV-1 previously was known to be endemic...
- [The profile of Israeli travelers to developing countries: perspectives of a travel clinic]Shmuel Stienlauf
The Center for Travel Medicine and Tropical Diseases, Chaim Sheba Medical Center, Tel Hashomer, Israel
Harefuah 149:559-62, 621. 2010..The number of Israeli travelers is increasing, including the number of travelers to developing countries...
- Effectiveness of short prophylactic course of atovaquone-proguanil in travelers to sub-saharan AfricaEyal Leshem
The Center for Geographic Medicine, The Chaim Sheba Medical Center, Tel Hashomer, Israel
J Travel Med 21:82-5. 2014..Evidence from clinical studies suggests that discontinuation of AP 1 day after exposure ends may be safe and effective. Our objective was to assess the effectiveness of short-course AP prophylaxis among travelers to sub-Saharan Africa...
- A large outbreak of Salmonella Paratyphi A infection among israeli travelers to NepalEyal Meltzer
Center for Geographic Medicine and Department of Medicine C, Sheba Medical Center, Tel Hashomer, and Sackler School of Medicine, Tel Aviv University, Ramat Gan, Israel
Clin Infect Dis 58:359-64. 2014..In Asia, Salmonella Paratyphi A is an emerging infection, and travelers are increasingly at risk. During October 2009-November 2009, an outbreak in S. Paratyphi A infection was noted in Israeli travelers returning from Nepal...
- Epidemiology of travel-related hospitalizationShmuel Stienlauf
Department of Internal Medicine C, Sheba Medical Center, Tel Aviv University, Israel
J Travel Med 12:136-41. 2005..Limited information exists on causes of hospitalization in patients returning from the tropics, and most is focused on febrile diseases. We evaluated all causes of post-travel hospitalization in a tertiary care hospital in Israel...
- Lymphomatoid granulomatosis: a diagnostic challengeRuth Percik
Department of Medicine C, Sheba Medical Center, Tel Hashomer, Israel
Isr Med Assoc J 7:198-9. 2005